BMT Tandem "Scientific" Meeting
Seaport Ballroom DE (Manchester Grand Hyatt)
Chairs:
Bipin N. Savani, MD
and
Paul Szabolcs, MD
Disclosures:
B. N. Savani,
Nothing To Disclose
P. Szabolcs,
Nothing To Disclose
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center;
Catherine Holtzapfel, NP, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Gregory Yanik, MD, University of Michigan;
Arlene Naranjo, PhD, Childrens Oncology Group;
Marguerite T. Parisi, MD, Seattle Childrens Hospital;
Barry L. Shulkin, MD, St. Jude Research Childrens Research Center;
Helen Nadel, MD, British Columbia Childrens Hospital;
Michael J Gelfand, MD, Cincinnati Childrens Hosptial Medical Center;
Ruth Ladenstein, MD, St. Anna Children's Hospital;
Ariane Boubaker, MD, Centre Hospitalier Universitaire Vaudois;
Ulrike Poetschger, PhD, St. Anna Children's Cancer Research Institute;
Dominique Valteau-Couanet, MD, Institut Gustave-Roussy;
Susan G Kreissman, MD, Duke University;
Julie R Park, MD, Seattle Children's Hospital;
Katherine K Matthay, MD, UCSF Medical Center
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Gregory A. Abel, MD, MPH, Dana-Farber Cancer Institute;
Randy Albelda, PhD, University of Massachusetts Boston;
Diana Y. Salas Coronado, MPA, Dana-Farber Cancer Institute;
Lyden Marcellot, Dana-Farber Cancer Institute;
Theresa Hahn, PhD, Roswell Park Cancer Institute;
Nandita Khera, MD, Mayo Clinic;
Reginald D. Tucker-Seeley, ScD, Dana-Farber Cancer Institute;
Kira Bona, MD, MPH, Dana-Farber Cancer Institute;
Oreofe O. Odejide, MD, Dana-Farber Cancer Institute;
Robert J. Soiffer, MD, Dana-Farber Cancer Institute
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Mukta Arora, MD, MS, University of Minnesota Medical Center;
Canlan Sun, PhD, City of Hope;
Kirsten Ness, PT PhD, St. Jude Children's Research Hospital;
Jennifer Berano Teh, MD, City of Hope;
Amy Schad, MPH, City of Hope;
Cara Hanby, CCRP, City of Hope;
Liton Francisco, City of Hope;
Karen Hou, City of Hope;
Jessica Wu, City of Hope;
Linus Kuo, City of Hope;
Saro H. Armenian, DO, MPH, City of Hope;
Daniel J. Weisdorf, MD, University of Minnesota Medical Center;
Stephen J. Forman, City of Hope Medical Center;
Smita Bhatia, MD, MPH, City of Hope National Medical Center
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Natasha A Jain, MD, National Heart, Lung, and Blood Institute, NIH;
Marcus Y Chen, MD, National Heart, Lung, and Blood Institute, NIH;
Sujata Shanbhag, MD, National Heart, Lung, and Blood Institute, NIH;
Prathima Anandi, MD, National Heart, Lung, and Blood Institute, NIH;
Kit Lu, MD, National Heart, Lung, and Blood Institute, NIH;
Priyanka A Pophali, MD, National Heart, Lung, and Blood Institute, NIH;
Neil Dunavin, MD, National Heart, Lung, and Blood Institute, NIH;
Sawa Ito, MD, National Heart, Lung, and Blood Institute, NIH;
Eleftheria Koklanaris, RN, National Heart, Lung, and Blood Institute, NIH;
Christopher S. Hourigan, MD, PhD, National Heart, Lung, and Blood Institute, NIH;
A. John Barrett, MD, National Heart, Lung, and Blood Institute, NIH;
Minoo Battiwalla, MD, MS, National Heart, Lung, and Blood Institute, NIH
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Carmem Bonfim, MD, Federal University of Paraná;
Lisandro Ribeiro, MD, Federal University of Paraná;
Samantha Nichele, MD, Federal University of Parana;
Marco Bitencourt, MD, Federal University of Parana;
Mary Eapen, MBBS, MS, CIBMTR/Medical College of Wisconsin;
Mary E. D. Flowers, MD, Fred Hutchinson Cancer Research Center;
Gisele Loth, MD, Federal University of Paraná;
Cilmara Kuwahara, MD, Hospital Infantil Pequeno Príncipe;
Ana Luiza Melo Rodrigues, MD, Federal University of Parana;
Vaneuza Araujo Moreira Funke, MD, MS, Federal University of Parana;
Ricardo Pasquini, MD, Federal University of Parana
![[Visit Client Website]](images/banner.gif)